What should practice staff do if an exosome shipment arrives with depleted dry ice?

If dry ice is completely sublimated upon arrival, immediately check the embedded temperature logger to see if internal temperatures rose above recommended thresholds. Do not administer the product; place the vials into a quarantined -80°C freezer and contact your distributor immediately with photos and logger data.

Can frozen MSC exosomes be stored in a standard commercial -20°C freezer?

No, standard -20°C medical or laboratory freezers are insufficient for long-term exosome stability. MSC-derived exosomes require ultra-low temperature storage (-80°C) or liquid nitrogen vapor phases to prevent lipid membrane degradation and payload loss over time.

How long can exosomes remain at room temperature before administration?

Once controlled thawing begins, exosomes should generally be administered within a strict window specified by the manufacturer, typically under 2 to 4 hours when kept on ice. Unused thawed product should never be re-frozen, as repeated freeze-thaw cycles destroy extracellular vesicle integrity.

What documentation is required to maintain compliance when receiving biological allografts?

Practices should retain the physical packing manifest, Certificate of Analysis (CoA), signed receiving log with timestamps, and exported temperature logger data. Storing these records in your compliance binder or EMR ensures full traceability from donor lot to patient application.

Who should be trained on the exosome receiving standard operating procedure?

All staff members authorized to sign for deliveries—including front-desk receptionists, office managers, medical assistants, and inventory coordinators—must be trained on cold-chain intake to prevent shipments from sitting unmanaged at ambient temperatures.

SOPs for Receiving Frozen MSC Exosome Shipments

Standard operating procedures for receiving frozen MSC exosome shipments require immediate verification of package integrity, dry ice volume, and temperature indicator status upon delivery. Practice staff must confirm lot numbers against the chain-of-custody documentation and immediately transfer vials into a calibrated ultra-low temperature (-80°C) freezer. Establishing formal receiving protocols safeguards biological efficacy, prevents costly inventory loss, and ensures regulatory compliance for clinical practices.

Establishing Intake Protocols for Frozen Regenerative Biologics

When adding extracellular vesicles and mesenchymal stem cell (MSC) derivatives to your service line, procurement control extends far beyond vendor selection. High-potency biologics are highly sensitive to thermal fluctuations. The moment a courier delivers a insulated shipping container to your clinical clinic, the clock begins ticking on cold-chain validation.

Having a documented Standard Operating Procedure (SOP) ensures that clinical administrative staff and medical assistants execute intake with precision. Without formal protocols, shipments risk lingering at front-desk reception areas, suffering unrecorded temperature excursions, or being stored at inappropriate temperatures—compromises that degrade product potency and expose the practice to financial loss.

A robust receiving SOP addresses four primary operational pillars:

Physical Container Inspection: Validating the external packaging for structural damage, punctures, or improper courier orientation.
Thermal Chain Validation: Examining data loggers or chemical indicators to confirm temperatures remained within target thresholds during transit.
Inventory & Lot Reconciliation: Cross-referencing manifest details, certificates of analysis (CoAs), and physical vial labeling.
Storage Chain Transfer: Executing rapid transfer to designated ultra-low temperature freezers to prevent partial thawing.

The Step-by-Step Exosome Receiving Checklist

To standardize workflow among clinical support staff, practices should maintain a printed or digital checklist at the clinical receiving station. Staff members handling incoming shipments should wear appropriate personal protective equipment (PPE), including insulated cryogenic gloves and face shields, when handling dry ice.

Intake Checklist for Clinical Receiving Staff

Step 1: Sign and Timestamp Arrival — Record the exact time of delivery and log courier details. Do not allow packages containing cold-chain biologics to sit unmanaged in common receiving areas.
Step 2: Inspect External Shipping Box — Check for crushing, wetness, torn tape, or compromised tamper-evident seals. Document any physical abnormalities on the courier receipt and take clear photographs.
Step 3: Open Container and Check Refrigerant — Open the outer carton and insulated styrofoam box. Verify the presence of remaining dry ice. If dry ice is fully sublimated, note this immediately on the intake log.
Step 4: Audit Temperature Data Logger — Stop the electronic temperature logger (or inspect the chemical temperature card) embedded inside the container. Check for alarm status indicators showing temperature excursions above -50°C during transit.
Step 5: Reconcile Product Vials and Documentation — Remove product packaging without exposing individual vials to ambient room temperature longer than necessary. Match product names, lot numbers, vial counts, and expiration dates against the enclosed packing slip and Certificate of Analysis.
Step 6: Execute Immediate Ultra-Low Transfer — Place the frozen exosome vials directly into the practice’s dedicated -80°C freezer or liquid nitrogen storage unit. Log the destination freezer ID, shelf location, and final placement time.
Step 7: File Chain-of-Custody Records — Archive the receipt log, CoA, temperature logger data file, and packing manifest into your practice management software or compliance binder.

Storage Requirements and Cold-Chain Maintenance

Unlike traditional pharmacological agents or room-temperature medical supplies, MSC-derived exosomes require stringent thermal controls. Long-term stability relies on maintaining the structural integrity of the lipid bilayer membrane encapsulating the trophic factors, microRNAs, and signaling proteins.

Equipment Guidelines for Practice Administrators

Primary Storage (-80°C): Standard commercial freezers (-20°C) are insufficient for multi-month storage of frozen exosomes. Practices must utilize validated medical-grade ultra-low temperature (ULT) freezers designed to maintain -80°C to -86°C.
Continuous Monitoring: Install calibrated continuous temperature monitoring probes linked to automated notification systems. In the event of a power outage or mechanical failure, key personnel must receive instant alerts.
Emergency Back-up Plan: Maintain an emergency action plan specifying an alternative -80°C storage location or a dedicated dry ice reserve protocol in case of primary freezer malfunction.

Clinical Considerations: Preserving Vesicle Integrity

While practice managers oversee compliance and cost management, treating clinicians must trust that the biologic delivered to the procedure room matches the potency claimed on the manufacturer's data sheet. For regenerative medicine doctors, improper receiving protocols introduce uncontrolled variables into patient care.

Why Temperature Control Dictates Clinical Success

Exosomes function via cell-to-cell signaling. When frozen exosomes experience repeated micro-thaw cycles—often caused by ambient exposure during slow receiving procedures—the lipid membrane can rupture. Premature membrane cleavage releases delicate internal payloads into extracellular fluid prior to target tissue administration, drastically reducing bioactivity.

Clinicians should require that receiving staff never leave biological vials on countertops while reviewing paperwork. Inspection and logging must occur rapidly, or inside a cold environment, ensuring the product stays at sub-zero temperatures until clinical reconstitution or controlled thawing immediately prior to patient application.

Managing Deviations, Quarantines, and Vendor Communication

When a shipment fails inspection—due to a triggered temperature logger, missing dry ice, damaged vials, or mismatched lot numbers—staff must execute a formal quarantine procedure rather than returning or discarding the product immediately.

Quarantine Protocol Steps

Isolate the Product: Place the compromised vials inside a designated, clearly labeled "QUARANTINE - DO NOT USE" box within the -80°C freezer to prevent accidental clinical deployment.
Notify Distributor Immediately: Contact your biologic distribution representative within the contractually required notification window (typically within 24 hours of delivery).
Provide Documentation: Export the temperature logger report, attach photos of the outer packaging and dry ice status, and send a copy of the intake log.
Await Vendor Disposition: Keep the product quarantined until the vendor issues a Return Merchandise Authorization (RMA) or written clearance based on quality assurance evaluation.

Reviewing vendor compliance guidelines in our frequently asked questions section can help practice managers establish clear contractual expectations regarding transit guarantees and replacement policies.

What This Means for Your Practice

Standardizing your exosome receiving protocol reduces operational friction, protects high-value inventory, and ensures compliance with state tissue distribution regulations.

Immediate Action Steps for Practice Managers:

Draft a Dedicated SOP: Customize the checklist above into your clinical Operations Manual and display a copy near your primary receiving station.
Train Reception and Clinical Assistants: Conduct a hands-on training session covering PPE usage, temperature logger extraction, and rapid freezer transfer.
Audit Storage Infrastructure: Verify that your practice freezer maintains calibrated -80°C temperatures with active alarm telemetry before taking delivery of new biologic inventory.
Establish Vendor Communication Protocols: Ensure your team knows who to contact immediately if a thermal excursion occurs during transit.

To discuss high-potency biological procurement, cold-chain compliance, or practice integration strategies, contact Dallas Regenerative Solutions to speak with an experienced medical device and biologic strategist.